Does ETHOSUXIMIDE Cause Salivary hypersecretion? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Salivary hypersecretion have been filed in association with ETHOSUXIMIDE (ETHOSUXIMIDE). This represents 0.4% of all adverse event reports for ETHOSUXIMIDE.
5
Reports of Salivary hypersecretion with ETHOSUXIMIDE
0.4%
of all ETHOSUXIMIDE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Salivary hypersecretion From ETHOSUXIMIDE?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETHOSUXIMIDE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ETHOSUXIMIDE Cause?
Drug ineffective (342)
Seizure (160)
Off label use (116)
Treatment failure (102)
Multiple-drug resistance (84)
Generalised tonic-clonic seizure (81)
Somnolence (72)
Fatigue (63)
Epilepsy (58)
Ataxia (57)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which ETHOSUXIMIDE Alternatives Have Lower Salivary hypersecretion Risk?
ETHOSUXIMIDE vs ETHYL ICOSAPENTATE
ETHOSUXIMIDE vs ETHYL LOFLAZEPATE
ETHOSUXIMIDE vs ETHYLENE GLYCOL
ETHOSUXIMIDE vs ETIFOXINE
ETHOSUXIMIDE vs ETIZOLAM